Mirabella Financial Services’s Maravai LifeSciences MRVI Stock Holding History

Mirabella Financial Services’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,110,545	Closed	-$6.86M	–	1081
2025 Q4	$6.86M	Sell	2,110,545 -1,639,455	-44%	-$5.52M	0.64%	21
2025 Q3	$10.8M	Hold	3,750,000	–	–	0.93%	21
2025 Q2	$9.04M	Buy	3,750,000 +10,049	+0.3%	+$21.1K	0.93%	25
2025 Q1	$8.27M	Buy	+3,739,951	New	+$14.8M	0.34%	55
2022 Q4	–	Sell	-39,964	Closed	-$1.02M	–	470
2022 Q3	$1.02M	Buy	+39,964	New	+$1M	0.11%	111
2022 Q2	–	Sell	-35,439	Closed	-$1.25M	–	626
2022 Q1	$1.25M	Buy	+35,439	New	+$1.19M	0.14%	138
2021 Q4	–	Sell	-60,645	Closed	-$2.98M	–	541
2021 Q3	$2.98M	Buy	60,645 +26,073	+75%	+$1.27M	0.39%	68
2021 Q2	$1.44M	Buy	34,572 +16,835	+95%	+$652K	0.26%	109
2021 Q1	$632K	Sell	17,737 -3,403	-16%	-$113K	0.2%	113
2020 Q4	$593K	Buy	+21,140	New	+$589K	0.07%	164

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

1WCM

12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Mirabella Financial Services's MRVI Position: Q1 2026 in Review

Mirabella Financial Services sold out of Maravai LifeSciences (MRVI) in Q1 2026, closing a stake of 2,110,545 shares — an estimated $6.86M sold.

Mirabella Financial Services first reported a position in MRVI in Q4 2020 and held it in 10 quarters. The position peaked at $10.8M in Q3 2025. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

Mirabella Financial Services reported no remaining Maravai LifeSciences position as of Q1 2026 after selling out during the quarter.
Mirabella Financial Services sold 2,110,545 Maravai LifeSciences shares in Q1 2026, an estimated $6.86M.
Mirabella Financial Services first reported a position in Maravai LifeSciences in Q4 2020 and held it in 10 quarters.
Mirabella Financial Services's Maravai LifeSciences position peaked at $10.8M in Q3 2025.
158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Mirabella Financial Services's 13F filing for Q1 2026, filed 12 May 2026.